The DOJ intervened in a FCA case alleging that Arriva Medical LLC (Arriva) and its parent Alere Inc. (Alere) charged Medicare for unnecessary
A development out of the Ninth Circuit makes relators more likely to qualify as an original source under the False Claims Act and thus survive the
The latest False Claims Act settlements indicate that the Anti-Kickback Statute continues to be an enforcement priority and a key tool for identifying
Life science companies, health care providers, and government contractors will be at risk for significantly larger penalties due to substantial
In January, the US District Court for the Northern District of New York dismissed a False Claims Act (FCA) case brought by a whistleblower against Dialysis Clinic Inc. (DCI).